CD56-Negative Extranodal Natural Killer/T-Cell Lymphoma: A Retrospective Study in 443 Patients Treated by Chemotherapy With or Without Asparaginase

CD56-Negative Extranodal Natural Killer/T-Cell Lymphoma: A Retrospective Study in 443 Patients Treated by Chemotherapy With or Without Asparaginase

ObjectiveExtranodal natural killer/T cell lymphoma (NKTCL) is an aggressive EBV-related lymphoma, originating from NK cells or T cells. Previous study demonstrated that CD56 negative NKTCL should be recognized as a distinct subtype. In this study, the value of CD56 in NKTCL is validated in the era o...

Full description

Bibliographic Details
Main Authors: Jing Yang, Pengfei Li, Yingshi Piao, Xindi Liu, Liqiang Wei, Wei Sang, Luo Zhang, Liang Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Immunology
Subjects:
extranodal natural killer/T cell lymphoma
tumor microenvironment
prognosis
asparaginase
bioinformatics analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.829366/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.829366/full

Similar Items